NCT01847170View on ClinicalTrials.gov

Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease

PHASE1CompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

May 31, 2013

Primary Completion Date

November 30, 2016

Study Completion Date

November 30, 2016

Conditions
Crohn's Disease
Interventions
BIOLOGICAL

Fecal Microbial Transplantation

Trial Locations (1)

02215

Beth Israel Deaconess Medical Center, Boston

All Listed Sponsors
collaborator

The Broad Foundation

OTHER

collaborator

Brigham and Women's Hospital

OTHER

lead

Beth Israel Deaconess Medical Center

OTHER

NCT01847170 - Impact of Fecal Biotherapy (FBT) on Microbial Diversity in Patients With Moderate to Severe Inflammatory Bowel Disease | Biotech Hunter | Biotech Hunter